China’s first CAR-T Cell Therapy approved-Fosun Kite Axicabtagene Ciloleucel (FKC876)

The first* CAR-T cell therapy approved by NMPA: opening a new era of cell therapy in China Individualized living-cell-based medicine: genetically modify patient's T-cells to expresses a chimeric antigen receptor ...

Full "IntellAsia: Resources" article